Status:
WITHDRAWN
Personalized Management of Pancreatic Adenocarcinoma Using Patient-Derived Tumoroids
Lead Sponsor:
Mayo Clinic
Conditions:
Pancreas Adenocarcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is designed to prospectively investigate the feasibility of establishing patient-derived tumoroids (PDT) as a platform for a personalized approach for response prediction and guide optimal ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years of age.
- Have an ECOG Performance Status of ≤ 2.
- No evidence of distant metastasis on imaging.
- Histologic or cytologic proven adenocarcinoma of the pancreas.
- Providing informed consent prior to enrollment in the trial.
Exclusion
- Failure to obtain additional core needle biopsies for generating PDTs.
- Females who are pregnant or plan to become pregnant.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04821219
Start Date
January 1 2022
End Date
December 31 2023
Last Update
February 24 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.